US 6515003
Heterocyclic derivatives for the treatment of diabetes and other diseases
expired A61PA61P1/00A61P1/04
Quick answer
US patent 6515003 (Heterocyclic derivatives for the treatment of diabetes and other diseases) held by Maxim Pharmaceuticals, Inc. expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Maxim Pharmaceuticals, Inc.
- Grant date
- Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/00, A61P15/00